AssetMark’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCVX
AssetMark's PCVX Position: Q3 2026 in Review
AssetMark increased its Vaxcyte (PCVX) stake by 79% in Q3 2026, buying an estimated $85.7K and bringing the position to 3,321 shares worth $189K. The position accounts for ﹤0.01% of the portfolio, ranked #1478.
AssetMark first reported a position in PCVX in Q3 2024 and has held it in 9 quarters since. The position peaked at $545K in Q1 2025. 266 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.
- AssetMark held 3,321 shares of Vaxcyte worth $189K as of Q3 2026.
- AssetMark bought 1,470 Vaxcyte shares in Q3 2026, an estimated $85.7K.
- Vaxcyte made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #1478 holding.
- AssetMark first reported a position in Vaxcyte in Q3 2024 and has held it in 9 quarters since.
- AssetMark's Vaxcyte position peaked at $545K in Q1 2025.
- 266 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.